CalbaTech, Inc. Announces Launch Date For Stem Cell Microbank(TM) And Date For Dividend ‘Coupon’ To Shareholders Of Record As Of August 10, 2006

IRVINE, Calif., July 24 /PRNewswire-FirstCall/ -- CalbaTech, Inc. , an emerging life sciences company (http://www.CalbaTech.com) concentrating on banking adult stem cells for possible future therapeutic uses and providing products and platforms to the biotech, pharmaceutical research market and to academic institutions, announced today that its wholly owned subsidiary, LifeStem, Inc. will begin operations of its Adult Stem Cell Microbank(TM) collection service on August 15th 2006.

LifeStem's Stem Cell Microbank(TM) Service is the nation's first service to collect micro quantities of adult stem cells from multiple tissue sources. "We have completed the validation of our protocols to guarantee that our service will run smoothly at the time of launch," said James DeOlden, CEO. "LifeStem and its partners are now satisfied with the vitality and viability of the cells that have been collected."

A number of individuals have already expressed interest in being the first to store their stem cells with LifeStem once the Service has begun. The company will begin enrolling clients immediately. LifeStem will also begin its marketing efforts immediately to take advantage of the time between today's date and the 15th of August to schedule other individual's stem cell harvests.

Additionally, CalbaTech, in coordination with LifeStem, announced that it will be offering a ten percent discount coupon for LifeStem's Stem Cell Microbank(TM) collection service, to shareholders of record as of August 10, 2006. The discount is available to the individual shareholder, or any member of the shareholder's immediate family at the shareholder's listed address.

CalbaTech's wholly owned subsidiary LifeStem has developed a unique process to harvest stem cells from two tissue sources, in micro quantities, to be cryopreserved for possible future therapeutic use. The collection of stem cells from two different tissue sources increases the potential for possible treatment options of more diseases.

About CalbaTech

CalbaTech, Inc. is an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions.

Contact: Paul Knopick E&E Communications (949) 707-5365 pknopick@eandecommunications.com

Note: Certain statements in this news release may contain "forward- looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to being in a large and growing market, exhibiting rapid growth characteristics, and having a growth strategy, are forward looking statements. These forward looking statements are only predictions and are subject to certain risks, uncertainties and assumptions. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or assumptions in this press release include the risk that we will not be able to grow our revenues and market share, the risk that our prices do not remain competitive and the risk that we will not achieve profitability. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission, including our most recent Report on Form 10-KSB, and Reports on Form 10-QSB and Form 8-K. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

Contact: Paul Knopick E&E Communications (949) 707-5365 pknopick@eandecommunications.com

CalbaTech, Inc.

CONTACT: Paul Knopick of E&E Communications for CalbaTech,+1-949-707-5365, pknopick@eandecommunications.com

MORE ON THIS TOPIC